You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Business & Finance
Shengtai Pharmaceutical Inc reports fiscal 2012 results
1 October 2012 - Shengtai Pharmaceutical Inc (OTC Bulletin Board: SGTI), a China-based manufacturer and distributor of glucose and starch as pharmaceutical raw materials and other starch and glucose products, reported its financial results for the twelve months ended June 30, 2012, on September 28, 2012.
The company posted sales revenue of USD179,029,127 in the fiscal 2012, up 4.26 percent compared to the same period in 2011.
The firm reported selling, general and administrative expenses of USD11,825,104 for the fiscal 2012, up 20.6 percent against USD9,805,044 for the year ended June 30, 2011.
The company posted sales revenue of USD179,029,127 in the fiscal 2012, up 4.26 percent compared to the same period in 2011.
The firm reported selling, general and administrative expenses of USD11,825,104 for the fiscal 2012, up 20.6 percent against USD9,805,044 for the year ended June 30, 2011.
Login
Related Headlines
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva